{"schema_version":"secwatch.filing_event.v1","accession":"0001937653-24-000049","form_type":"8-K","ticker":"ZYME","cik":"0001937653","company_name":"Zymeworks Inc.","filed_at":"2024-10-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.383030+00:00","generated_at":"2026-05-30T07:41:22.505076+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Zymeworks reports 9M 2024 net loss $99.2M; cash $374.9M; completes $30M buyback; advances pipeline","bullets":["Net loss $99.2M for nine months ended Sep 30, 2024 vs $104.2M loss prior year; revenue $45.3M vs $59.1M.","Cash resources $374.9M (cash, equivalents, marketable securities) as of Sep 30, 2024; projected runway into 2H 2027 including milestones.","Completed initial $30M share repurchase: 2,545,402 shares at avg $11.79 as of Oct 31, 2024.","First patient dosed in Phase 1 trial of ZW171 for MSLN-expressing cancers; preclinical data presented for ZW220 and ZW251.","Director Hollings C. Renton resigns from board effective Dec 10, 2024; not due to disagreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001937653-24-000049","json":"https://secwatch.observer/filing/0001937653-24-000049.json","markdown":"https://secwatch.observer/filing/0001937653-24-000049.md","text":"https://secwatch.observer/filing/0001937653-24-000049.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1937653/000193765324000049/0001937653-24-000049-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1937653/000193765324000049/zyme-20241031.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T07:41:22.505076+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}